Skip to main content
Caplight Logo









nRichDX

nRichDX

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://nrichdx.com

Last Round

VC Round

Jun 17, 2020

Momentum

Top 1%

of companies Caplight tracks

Company Overview

nRichDX operates in Healthcare & Life Sciences and is based in Irvine, California. Its latest recorded funding round was a VC Round in June 2020.

nRichDX is a life sciences company that provides automated sample preparation systems and kits for liquid biopsy applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

nRichDX Comparables

Compare nRichDX with similar companies based on industry and business-model similarity.

nRichDX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Avant Genomics
86%
Tethis S.p.A.
80%
Enumera Molecular
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

nRichDX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 17, 2020
VC RoundJun 27, 2018
VC RoundNov 7, 2016
VC RoundJul 16, 2015
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Bill Curtis

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 2, 2026

    Open roles increased to 7, 29% of headcount.

  • Jul 25, 2026

    Monthly visitors grew 95% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

nRichDX Filings

Explore SEC and related filing metadata, where available.

nRichDX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about nRichDX's valuation, stock price, and market status.

Is nRichDX a public or private company?

nRichDX is a private company.

What is the current stock price of nRichDX?

nRichDX is a private company, so its shares have no public market price. Caplight tracks nRichDX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is nRichDX worth (valuation)?

Valuation information for nRichDX is not publicly available.

Can I buy nRichDX stock?

nRichDX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was nRichDX's last funding round?

nRichDX's most recent funding round was VC Round on June 17, 2020.

Who are the main investors in nRichDX?

Investor information for nRichDX is not publicly disclosed.

Will nRichDX IPO soon?

No public IPO plans have been announced for nRichDX.

How can I track nRichDX secondary market activity?

Caplight tracks bids, offers, and trades in nRichDX's shares on secondary markets.

Firmographic Details

HeadquartersIrvine, California
Employee Range17
Year Founded2016
Last FundingJun 17, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?